Search

Your search keyword '"Medisch Oncologische Disciplines"' showing total 83 results

Search Constraints

Start Over You searched for: Author "Medisch Oncologische Disciplines" Remove constraint Author: "Medisch Oncologische Disciplines"
83 results on '"Medisch Oncologische Disciplines"'

Search Results

1. Individualized trajectories in postradiotherapy neurocognitive functioning of patients with brain metastases

2. Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design(Trials, (2023), 25, 401, 10.1186/s13063-024-08223-5)

3. Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months

4. Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma

6. Patient values in patient-provider communication about participation in early phase clinical cancer trials: a qualitative analysis before and after implementation of an online value clarification tool intervention

7. Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma

9. Erratum: Correction: A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues (Life science alliance (2024) 7 8 PII: e202402889 DOI: 10.26508/lsa.202402730)

10. Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma

11. Extrahepatic perfusion and incomplete hepatic perfusion after hepatic arterial infusion pump implantation: incidence and clinical implications

12. Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma

14. Improving sustainability of a patient decision aid for systemic treatment of metastatic colorectal cancer: A qualitative study

15. Use of automated assessment for determining associations of low muscle mass and muscle loss with overall survival in patients with colorectal cancer – A validation study

16. The Assessment of Burden of ColoRectal Cancer (ABCRC)-tool; a validity and reliability study

17. Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide study

18. The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis

19. Value of Real-World Evidence for Treatment Selection: A Case Study in Colon Cancer

20. Tumor-Infiltrating Lymphocytes in Patients with Stage i Triple-Negative Breast Cancer Untreated with Chemotherapy

21. Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma with BRCA -Like Genomic Aberrations

22. Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

23. Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study

24. Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort

25. The effect of administering preprocedural VITamin K on the international normalized ratio in patients anticoagulated with ACEnocoumarol (VITKACE-study): a prospective cohort study

26. Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

27. Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group

30. A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial

31. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis

32. What patients with advanced cancer experience as helpful in navigating their life with a long-term response: a qualitative study

33. Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancer

34. Corrigendum to “Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer”: [Annals of Oncology 33 (2022) 769–785, (S092375342201167X), (10.1016/j.annonc.2022.05.006)]

35. High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation

36. A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide

37. Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study)

38. Towards patient-led follow-up after curative surgical resection of stage I, II and III colorectal cancer (DISTANCE-trial): a study protocol for a stepped-wedge cluster-randomised trial

39. Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer

40. Author Correction: Possible alleviation of symptoms and side effects through clinicians’ nocebo information and empathy in an experimental video vignette study (Scientific Reports, (2022), 12, 1, (16112), 10.1038/s41598-022-19729-w)

41. Clinical development of WEE1 inhibitors in gynecological cancers: A systematic review

42. Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study

43. Identifying the BRCA1 c.-107A > T variant in Dutch patients with a tumor BRCA1 promoter hypermethylation

44. Standardized item selection for alternate computerized versions of Rey Auditory Verbal Learning Test(-based) word lists

45. Comments on the CAIRO4 Trial Secondary Outcomes Report-Reply

46. Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study

47. Mind your words: Oncologists' communication that potentially harms patients with advanced cancer: A survey on patient perspectives

48. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer

49. BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site-specific metastasis by stimulating glutathione synthesis

50. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study

Catalog

Books, media, physical & digital resources